122 related articles for article (PubMed ID: 34191696)
1. Oxypeucedanin is a Mechanism-based Inactivator of CYP2B6 and CYP2D6.
Zhang K; Li Y; Fu Y; Cui T; Wang Q; Mao X; Peng Y; Zheng J
Curr Drug Metab; 2021; 22(11):882-892. PubMed ID: 34191696
[TBL] [Abstract][Full Text] [Related]
2. Imperatorin is a mechanism-based inactivator of CYP2B6.
Zheng L; Cao J; Lu D; Ji L; Peng Y; Zheng J
Drug Metab Dispos; 2015 Jan; 43(1):82-8. PubMed ID: 25378064
[TBL] [Abstract][Full Text] [Related]
3. Psoralen, a mechanism-based inactivator of CYP2B6.
Ji L; Lu D; Cao J; Zheng L; Peng Y; Zheng J
Chem Biol Interact; 2015 Oct; 240():346-52. PubMed ID: 26335194
[TBL] [Abstract][Full Text] [Related]
4. Mechanism-based inactivation of cytochrome P450 2B6 by isoimperatorin.
Cao J; Zheng L; Ji L; Lu D; Peng Y; Zheng J
Chem Biol Interact; 2015 Jan; 226():23-9. PubMed ID: 25500267
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inactivation of cytochrome P450 2B6 by isopsoralen.
Lu D; Ji L; Zheng L; Cao J; Peng Y; Zheng J
Xenobiotica; 2016; 46(4):335-41. PubMed ID: 26338349
[TBL] [Abstract][Full Text] [Related]
6. Nitidine Chloride Is a Mechanism-Based Inactivator of CYP2D6.
Mao X; Hu Z; Wang Q; Zhang N; Zhou S; Peng Y; Zheng J
Drug Metab Dispos; 2018 Aug; 46(8):1137-1145. PubMed ID: 29773554
[TBL] [Abstract][Full Text] [Related]
7. The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6.
Madeira M; Levine M; Chang TK; Mirfazaelian A; Bellward GD
Drug Metab Dispos; 2004 Apr; 32(4):460-7. PubMed ID: 16680870
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions.
Liu S; Wang Z; Chan E; Zhao Y; Kang J; Zhang X; Tian X
Chem Biol Interact; 2022 Jan; 352():109775. PubMed ID: 34910929
[TBL] [Abstract][Full Text] [Related]
9. Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine.
Bertelsen KM; Venkatakrishnan K; Von Moltke LL; Obach RS; Greenblatt DJ
Drug Metab Dispos; 2003 Mar; 31(3):289-93. PubMed ID: 12584155
[TBL] [Abstract][Full Text] [Related]
10. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
Bae SH; Kwon MJ; Choi EJ; Zheng YF; Yoon KD; Liu KH; Bae SK
Chem Biol Interact; 2013 Sep; 205(1):11-9. PubMed ID: 23777987
[TBL] [Abstract][Full Text] [Related]
11. Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.
Chang Y; Fang WB; Lin SN; Moody DE
Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):55-62. PubMed ID: 20825389
[TBL] [Abstract][Full Text] [Related]
12. Mechanism-based inactivation of cytochrome P450 2D6 by chelidonine.
Liu Y; Cui T; Peng Y; Ji M; Zheng J
J Biochem Mol Toxicol; 2019 Feb; 33(2):e22251. PubMed ID: 30368994
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inactivation of cytochrome P450 2D6 by Notopterol.
Fu Y; Tian X; Han L; Li Y; Peng Y; Zheng J
Chem Biol Interact; 2020 May; 322():109053. PubMed ID: 32198085
[TBL] [Abstract][Full Text] [Related]
14. Investigation of CYP2B6, 3A4 and β-esterase interactions of Withania somnifera (L.) dunal in human liver microsomes and HepG2 cells.
Kumar S; Bouic PJ; Rosenkranz B
J Ethnopharmacol; 2021 Apr; 270():113766. PubMed ID: 33395575
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
[TBL] [Abstract][Full Text] [Related]
16. NADPH-Independent Inactivation of CYP2B6 and NADPH-Dependent Inactivation of CYP3A4/5 by PBD: Potential Implication for Assessing Covalent Modulators for Time-Dependent Inhibition.
Kosaka M; Zhang D; Wong S; Yan Z
Drug Metab Dispos; 2020 Aug; 48(8):655-661. PubMed ID: 32482757
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes.
Liu L; Sun S; Rui H; Li X
Pharm Biol; 2017 Dec; 55(1):1868-1874. PubMed ID: 28614988
[TBL] [Abstract][Full Text] [Related]
18. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
[TBL] [Abstract][Full Text] [Related]
19. Guanfu base A, an antiarrhythmic alkaloid of Aconitum coreanum, Is a CYP2D6 inhibitor of human, monkey, and dog isoforms.
Sun J; Peng Y; Wu H; Zhang X; Zhong Y; Xiao Y; Zhang F; Qi H; Shang L; Zhu J; Sun Y; Liu K; Liu J; A J; Ho RJ; Wang G
Drug Metab Dispos; 2015 May; 43(5):713-24. PubMed ID: 25681130
[TBL] [Abstract][Full Text] [Related]
20. Tofacitinib Is a Mechanism-Based Inactivator of Cytochrome P450 3A4.
Guo X; Li W; Li Q; Chen Y; Zhao G; Peng Y; Zheng J
Chem Res Toxicol; 2019 Sep; 32(9):1791-1800. PubMed ID: 31414593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]